Baxter
BAX
HK$257.99
Share price
-0.75%
Change (1 day)
-21.10%
Change (1 year)
Categories
Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
Baxter (BAX) - Net assets
Net assets on the balance sheet as of December 2024 : HK$54.59 Billion
According to Baxter's latest financial reports the company has HK$54.59 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Baxter - Net assets on balance sheet (from 2001 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $HK$54.53 B | -17.55% |
| 2023-12-31 | $HK$66.13 B | 43.59% |
| 2022-12-31 | $HK$46.05 B | -35.24% |
| 2021-12-31 | $HK$71.12 B | 5.14% |
| 2020-12-31 | $HK$67.64 B | 9.78% |
| 2019-12-31 | $HK$61.61 B | 0.04% |
| 2018-12-31 | $HK$61.59 B | -13.51% |
| 2017-12-31 | $HK$71.22 B | 10.93% |
| 2016-12-31 | $HK$64.20 B | -6.55% |
| 2015-12-31 | $HK$68.71 B | 8.61% |
| 2014-12-31 | $HK$63.26 B | -3.86% |
| 2013-12-31 | $HK$65.80 B | 21.66% |
| 2012-12-31 | $HK$54.08 B | 1.99% |
| 2011-12-31 | $HK$53.03 B | 0.27% |
| 2010-12-31 | $HK$52.88 B | -8.07% |
| 2009-12-31 | $HK$57.53 B | 19.52% |
| 2008-12-31 | $HK$48.13 B | -10.74% |
| 2007-12-31 | $HK$53.92 B | 10.54% |
| 2006-12-31 | $HK$48.78 B | 46.35% |
| 2005-12-31 | $HK$33.33 B | 15.77% |
| 2004-12-31 | $HK$28.79 B | 13.46% |
| 2003-12-31 | $HK$25.37 B | 10.72% |
| 2002-12-31 | $HK$22.91 B | -21.76% |
| 2001-12-31 | $HK$29.29 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | -HK$22.71 Billion | -141.59% | 🇺🇸 USA |
 | HK$160.38 B | 193.76% | 🇺🇸 USA |
 | HK$171.02 B | 213.25% | 🇺🇸 USA |
 | HK$195.91 B | 258.83% | 🇺🇸 USA |
 | HK$2.82 B | -94.82% | 🇺🇸 USA |
 | HK$386.10 B | 607.18% | 🇺🇸 USA |
 | HK$4.39 B | -91.95% | 🇺🇸 USA |
 | HK$378.66 B | 593.56% | 🇮🇪 Ireland |
 | HK$15.27 B | -72.02% | 🇺🇸 USA |